Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "OS in Patients With Metastatic BRAF V600-Mutant Melanoma Treated With Encorafenib + Binimetinib: Real-World vs. Clinical Trial Data"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Gino In
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Gino In
73 views
November 24, 2023
Comments 0
Login to view comments.
Click here to Login
Skin